Michal Helbin is a highly experienced professional in the pharmaceutical industry with over 30 years of expertise, including more than 17 years in leadership roles within innovative Canadian firms. Currently, Michal serves as the Director of R&D Quality Assurance Strategic Advice at AstraZeneca while also contributing as a Technical Committee Member for HRSO-ONRH and an Accreditation Council Member for Human Research Accreditation Canada. Michal possesses a strong track record in quality assurance, regulatory compliance, and risk management, adeptly navigating complex regulatory environments and fostering compliance across global organizations. Previously, Michal held significant positions at companies such as ApoPharma Inc. and Bristol-Myers Squibb Corp., further solidifying a commitment to patient safety and data integrity. Educated with a Master's degree in Pharmacy from the Medical Academy University, Michal's insights are valuable in driving quality standards in research and development.
This person is not in the org chart
This person is not in any teams
This person is not in any offices